Iisrael - heebrea - Ministry of Health

teva israel ltd - tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - indicated for the treatment of : 1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv.2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease.

Iisrael - heebrea - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 16 mg

Iisrael - heebrea - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 3.6 mg

Iisrael - heebrea - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 5.4 mg

Iisrael - heebrea - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 16 mg

Iisrael - heebrea - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 3.6 mg

Iisrael - heebrea - Ministry of Health

zoetis israel holding b.v., israel - oclacitinib maleate - טבליות מצופות פילם - oclacitinib maleate 5.4 mg

Iisrael - heebrea - Ministry of Health

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Iisrael - heebrea - Ministry of Health

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Iisrael - heebrea - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine; zidovudine - טבליות מצופות פילם - lamivudine 150 mg; zidovudine 300 mg - lamivudine - lamivudine - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.